FIELD: medicine; oncology and endocrinology.
SUBSTANCE: invention can be used to determine predisposition to the development of thyroid cancer (TC). 32 risk factors are identified for the patient. Identified risk factors are assessed in points. According to the stated formula, the presence of a predisposition to thyroid cancer (S) is determined. When the S value is in the range of 1% and above, a high risk of developing thyroid cancer is determined. When the S value is below 0, the risk of developing thyroid cancer is low.
EFFECT: method provides increased effectiveness in the prevention of malignant neoplasms of the thyroid gland.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING RISK OF DEVELOPING CANCER OF ORAL MUCOSA | 2023 |
|
RU2825713C1 |
METHOD OF SELECTING PATIENTS IN THE LUNG CANCER RISK GROUP | 2017 |
|
RU2644703C1 |
METHOD FOR DETERMINING AGGRESSIVENESS OF LUNG CANCER | 2019 |
|
RU2724398C1 |
METHOD FOR DETERMINING PROSTATE CANCER RISK | 2018 |
|
RU2692987C1 |
METHOD FOR DETERMINING PROPENSITY FOR ONCOLOGICAL DISEASES | 2010 |
|
RU2475184C2 |
METHOD FOR DETERMINING THE BREAST CANCER RISK BY LAZAREV | 2017 |
|
RU2651131C1 |
METHOD FOR ASSESSING THE RISK OF THYROID CANCER IN A PATIENT WITH NODULAR THYROID FORMATIONS | 2019 |
|
RU2725749C1 |
METHOD FOR PREDICTION OF RISK OF HYPERTENSION IN MALES | 2011 |
|
RU2456608C1 |
METHOD FOR EVALUATING PNEUMONIC SEVERITY DEGREE | 2005 |
|
RU2294133C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING AN ISCHEMIC STROKE, TAKING INTO ACCOUNT GENETIC AND MEDIUM FACTORS | 2018 |
|
RU2679635C1 |
Authors
Dates
2024-01-31—Published
2023-03-27—Filed